Hello Heart
The aim is to expand Hello Heart's reach across patient populations by utilizing the Amwell platform.
The round comes nearly a year after the company announced it had raised $45 million in Series C financing.
The study enrolled more than 28,000 participants, and the follow-up period lasted as long as three years.
Livongo Health, Hinge Health, Hello Heart, Torchlight and Whil each underwent "rigorous clinical, data security and business evaluation" for inclusion in the program.
The company hopes the well-known consumer brand will make its program more accessible.
Hello Heart — maker of an app-driven platform designed to help employees manage hypertension, heart rate, and cardiovascular health — has announced the release of a new service for diabetes management.
Correction: This article previously mentioned strategic investors in MedoPad.
Redwood, California-based health app maker Hello Heart has raised $1.